Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
wound care
MedTech
Solventum to buy Acera for up to $850M, repurchase $1B in stock
Solventum, which spun out of 3M nearly two years ago, will shell out up to $850 million to acquire wound care specialist Acera Surgical.
Joseph Keenan
Nov 24, 2025 9:30am
Sanara MedTech drops tissue health platform as part of revamp
Nov 13, 2025 8:45am
Coloplast acquires fish-skin-based wound care company for $1.3B
Jul 7, 2023 10:42am
Bioventus seals up $85M sale of wound care business
May 23, 2023 12:24pm
ConvaTec breaks into wound biologics with $450M Triad buy
Jan 28, 2022 12:29pm
FDA clears battery-free surgical wound closure suction pump
Aug 25, 2021 11:46am
